Speakers

Raymond Osarogiagbon, MD
Chief Scientist, Baptist Memorial Healthcare Corporation
Director, Multidisciplinary Thoracic Oncology Program & Thoracic Oncology Research Group, Baptist Cancer Center

Dr. Osarogiagbon is Chief Scientist at the Baptist Memorial Healthcare Corporation, Director of the Multidisciplinary Thoracic Oncology Program and the Thoracic Oncology Research (ThOR) Group at the Baptist Cancer Center, in Memphis, Tennessee.

 

Kellie Jack, MPH
Community Outreach and Engagement Program Manager
Weill Cornell Medicine

Kellie Jack, MPH is the Community Outreach and Engagement Program Manager for the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. She is responsible for implementing and evaluating initiatives that seek to reduce the cancer burden and mortality rates in communities across Brooklyn, Queens, and areas of Manhattan, in partnership with community-based organizations and key community stakeholders. A native of Queens, New York, she is deeply committed to addressing health disparities among low-income and racial/ethnic minorities in NYC with a particular emphasis on increasing the representation of these groups on clinical trials.

 

Rachit Kumar, MD
Director of Clinical Research, Medical Oncology
Maine General Medical Center

Dr. Kumar is a medical oncologist and hematologist who sees patients at the Harold Alfond Center for Cancer Care and the Alfond Center for Health in Augusta. A member of MaineGeneral Medical Center's active staff, he joined the cancer staff in July 2017 after completing a hematology/oncology fellowship at Georgetown University/MedStar Washington Hospital Center in Washington, D.C. He received his medical degree from Maulana Azad Medical College, New Delhi, India and then did his internal medicine residency and chief residency at Georgetown University/MedStar Washington Hospital Center. His interests include targeted therapies and immunotherapy.

 

Gregory Tranah, PhD
Executive Director of Precision Medicine
Sutter Health

Dr. Tranah is the executive director of precision medicine at Sutter Health and an adjunct professor in the Department of Epidemiology and Biostatistics at the University of California, San Francisco.

In his position at Sutter Health, Dr. Tranah leads a research program dedicated to accelerating the translation of research discoveries related to health and aging to clinical settings across Sutter Health. The program focuses on novel treatments, diagnostic tests, wearable devices and other interventions that improve patient health and functioning.

As part of this effort he leads a team building a Sutter-wide biobank of 100,000 patients. This work has led to the launch of a large study of multiple sclerosis genomics to identify molecular predictors of disease progression and treatment response in patients from 10 Sutter clinics.

Dr. Tranah also leads the genomics core of a personalized medicine program at California Pacific Medical Center. The genomics core focuses on sequencing tumors to identify genomic predictors of treatment response for several highly malignant cancers. Dr. Tranah’s current research program focuses on identifying inherited and acquired genetic factors that impact aging and disease. The research program aims to revolutionize risk assessment by identifying widely applicable and inexpensive genomic tests that find those who would benefit from specific pharmacologic and behavioral treatments to prevent disability and disease.